The antitumoral mode of action of imiquimod and other imidazoquinolines.
about
Imiquimod for anogenital warts in non-immunocompromised adultsImiquimod for anogenital warts in non-immunocompromised adultsReciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumorsRandomized clinical trial of imiquimod: an adjunct to treating cervical dysplasiaRole of the store-operated calcium entry protein, STIM1, in neutrophil chemotaxis and infiltration into a murine model of psoriasis-inflamed skin.Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model.Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages.Update on toll-like receptor-directed therapies for human diseaseLack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reportsTLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.Computational structure-activity relationship analysis of non-peptide inducers of macrophage tumor necrosis factor-alpha production.TLR7 and TLR8 as targets in cancer therapy.Adenosine receptors in wound healing, fibrosis and angiogenesis.Treating skin cancer with topical cream.Changing pathology with changing drugs: skin cancer.Medical approaches to non-melanoma skin cancer.Imiquimod in the treatment of penile intraepithelial neoplasia: An update.Imiquimod in dermatology: an overview.Toll-like receptors and cutaneous melanoma.Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma.A new role for microRNAs, as ligands of Toll-like receptors.A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine.
P2860
Q24188125-24346298-FF5E-4EA5-8617-CD30601A608DQ24201332-454C9F60-3C0B-4867-A3FD-766E3415EEAFQ33766970-871B92F3-A0F4-4F9F-BD26-E58792DED850Q34777706-DE81D30B-CB45-451E-A6C4-F8E2209B069AQ35612975-8A7D9A0A-9499-40BB-A917-1FAD680E6151Q35774754-B501390F-1478-4A0D-8E50-3E4E8E22A0B4Q35865283-6C0BA1DE-193B-4545-A5B8-926866C58F5CQ35893267-2C098B94-265E-4104-BD6B-096166FE0900Q36171745-DECE5DBC-2516-4B3F-AED1-57A6755FEBD9Q36679216-D159AB63-0FC3-417A-8122-064E1C3D7301Q36941127-55A6ED0C-A371-49DB-B558-FB83CE1B4479Q36953375-AB6749CC-F2F8-4852-BB1F-171DC5B0A0CEQ36994175-26558E78-F17A-4241-A68E-1F636EDE9747Q37051014-2E426BC0-5F72-4202-9A36-177A20E26212Q37565195-DBFF0933-7927-45E2-A754-4C93B014B0DDQ37735187-904906B6-1E3A-42AF-9B88-A4BB1AC3108BQ37890206-72A27D83-CF82-49D9-9151-6726E2843113Q38162923-08DB2261-737F-4373-AA15-681841E1B1A6Q38764896-76EB2CAD-6AA7-40E3-A996-3DE998DD9770Q38888889-CD54C8D6-476B-4FB9-8508-ECBDF1E8B4E6Q39023996-9D50D3C7-CA19-4B6D-B658-9F90C26CB007Q39644046-A17FAF63-4A7C-4754-A27D-EF5A08B74F56Q41295458-559D4821-6C36-41A2-9898-46B0E53C2204Q44561634-A01DEEBB-A625-4C55-BF2F-1A2EEF07EAD0Q50891745-680578B8-0A33-4DCF-BB3C-70C82EBBB2ED
P2860
The antitumoral mode of action of imiquimod and other imidazoquinolines.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The antitumoral mode of action of imiquimod and other imidazoquinolines.
@en
type
label
The antitumoral mode of action of imiquimod and other imidazoquinolines.
@en
prefLabel
The antitumoral mode of action of imiquimod and other imidazoquinolines.
@en
P1476
The antitumoral mode of action of imiquimod and other imidazoquinolines.
@en
P2093
Margarete Schön
P304
P356
10.2174/092986707780059625
P577
2007-01-01T00:00:00Z